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A B S T R A C TObjective: To evaluate the reliability and validity of the Thai version
of the Kidney Disease Quality of Life 36 (KDQOL-36) questionnaire.
The KDQOL-36 questionnaire consists of the short-form 12 health
survey, and three dimensions of kidney disease questionnaires (the
Symptom/ Problem List, Effects of Kidney Disease on Daily Life, and
Burden of Kidney Disease). Methods: Subjects were 167 hemodialysis
patients and 62 peritoneal dialysis patients. Reliability was evaluated
by intraclass correlation coefficients for test-retest reliability assess-
ment with face-to-face interview and Cronbach’s alpha for internal
consistency. Construct validity was supported with convergent and
discriminant validity by using correlation between six-dimensional
health state short form (derived from short-form 36 health survey),
the EuroQol five-dimensional questionnaire, the visual analogue scale
parameter, and three dimensions of kidney disease questionnaires.see front matter Copyright & 2013, International
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.1016/j.vhri.2013.02.011
st: The authors have indicated that they have no
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dence to: P. Noparatayaporn, Department of PharmStatistical analysis included descriptive statistics, Mann-Whitney
U test, and Cronbach’s alpha. Results: Construct validity was satis-
factory, with the significant difference being less than 0.001 between
two groups (lowest through 25 percentile and higher than 75 percen-
tile). The reliability coefficient for the Cronbach’s alpha of the total
scale of the KDQOL-36 questionnaire was greater than 0.700 for all
domains, ranging from 0.706 to 0.827. Intraclass correlation coeffi-
cients ranged from 0.713 to 0.999. Conclusion: The Thai version of the
KDQOL-36 questionnaire is reliable and valid for evaluating the
quality of life in Thai dialysis patients.
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Copyright & 2013, International Society for Pharmacoeconomics and
Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Nowadays, the goal of patient care support is not only to extend
life but also to relieve suffering, restore functioning, or enhance
the quality of life. Health-related quality of life (HRQOL) is a
subjective health status that focuses more on the impact of a
perceived health state on the ability to live a fulfilling life [1].
Quality of life is important because long-term hemodialysis often
results in a loss of financial income, loss of freedom, dependence
on health care personnel and caregivers, and negative effect on
marital status, family, and social activities; thus, quality of life
should be measured and monitored for better understanding of
patients’ condition [2]. The end-stage renal disease (ESRD) is a
chronic health problem that cannot be cured, and the impact of
ESRD will reduce patients’ overall well-being and functioning [3].
The high prevalence of patients with ESRD is a worldwide public
health problem including in Thailand [4]. The disease-specific
quality-of-life questionnaire is one of the best andmost commonly
used instruments to evaluate quality of life [5]. The application of
quality-of-life score is in clinical care to predict the risk of death.
For example, Mapes et al. [6] found that patients who had dropped
10 points in the Physical Composite Score (PCS) in the Kidney
Disease Quality of Life – short form (KDQOL-SF) were associatedwith a 25% increased risk of death. DeOreo [7] found that
patients with PCS below the median (o34) were twice as likely to
die and 1.5 times more likely to be hospitalized when compared
with patients with PCS at or above the median score in his
study.
The short-form 36 health survey (SF-36) is a general ques-
tionnaire whose scores are transformed into a scale ranging from
0 to 100 [8]. The SF-36 has been widely used in the general
population and in patient populations to determine functional
status. It, however, is rather long, particularly for repeated use in
patients who are easily tired and have a chronic disease such as
ESRD; thus, its short version, the SF-12, is used. The Euroqol five-
dimensional (EQ-5D) questionnaire is the shorter instrument that
requires less time to complete. It consists of a questionnaire that
is classified into five elements, each with three levels, and a
visual analogue scale (VAS) that patients use to rate their own
health between 0 and 100. The evidence suggests that valuations
of health states could be different among people due to dissim-
ilarities in demographic backgrounds, sociocultural values, and
economic systems [9,10]. Thus, it is advisable to use country-
specific weights if available. Fortunately, the EQ-5D questionnaire
has been translated into Thai and validated in the Thai popula-
tions and is comfortable to use.Society for Pharmacoeconomics and Outcomes Research (ISPOR).
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Table 1 – Mean and reliability of kidney disease–specific scales.
Kidney disease–targeted scores Number of items Mean  SD Reliability
PD HD PD HD
Symptom/Problem List 12 74.89 14.97 80.45  14.68 0.763 0.799
Burden of Kidney Disease 4 80.43  16.91 49.25  33.67 0.781 0.802
Effects of Kidney Disease 8 52.52  32.86 68.81  24.18 0.706 0.827
HD, hemodialysis; PD, peritoneal dialysis.
VA L U E I N H E A LT H R E G I O N A L I S S U E S 2 ( 2 0 1 3 ) 9 8 – 1 0 2 99The KDQOL is a kidney disease–specific HRQOL instrument.
The first version of the KDQOL is the KDQOL–long form that
includes 134 questions that span 11 kidney disease–targeted scales.
The long-form questionnaire often leads to low responsiveness.
Thus, the KDQOL-SF v.1.3, which contains the SF-36 and 43 kidney
disease–specific items, was introduced to health care personnel
and is also available in Thai version. At present, the KDQOL-SF v.1.3
has been developed to a shorter version, known as the KDQOL-36
questionnaire. The KDQOL-36 questionnaire is the preferred mea-
surement tool for large-scale assessments in dialysis facilities
because of its ease of administration with relatively minimal
burden on patients and staff [1]. The KDQOL-36 consists of the
SF-12, which measures physical and mental functioning, Burden of
Kidney Disease subscale, Symptoms and Problems subscale, and
Effects of Kidney Disease on Daily Life subscale. The scores of the
KDQOL-36 questionnaire are transformed into 0 to 100, with higher
scores reflecting better quality of life. The SF-12 can estimate for all
eight domains but often focuses on the PCS and the Mental
Composite Score (MCS) [11]. Scale scores are computed with the
KDQOL-36TM scoring program [12].
No study, however, has reported the reliability and validity of
the Thai version of the KDQOL-36 questionnaire. The objective of
this study was to evaluate the reliability and validity of the
KDQOL-36 questionnaire in Thai patients with ESRD.Methods
Study Design and Subjects
One hundred and sixty-seven hemodialysis (HD) patients and 62
peritoneal dialysis (PD) patients were recruited from the outpatient
chronic hemodialysis clinic and chronic peritoneal dialysis clinic
at Siriraj Hospital between April and August 2011. The inclusion
criteria were patients with ESRD receiving chronic hemodialysis or
peritoneal dialysis for more than 3 months, and the exclusion
criteria were patients younger than 18 years, changed the modality
of dialysis between the study, and who could not answer the
questionnaire and were not willing to participate in the study.
When the patient gave informed consent, the investigator admin-
istered the KDQOL-36 questionnaire, the EQ-5D questionnaire, and
the VAS by face-to-face interview. The sociodemographic and
clinical data and review of medical records were recorded.
Scoring
For utility, the EQ-5D questionnaire score used the UK and Thai
preference weights because the EQ-5D questionnaire score origi-
nally used the value set from the United Kingdom and Thai value
set was available [13,14]. The VAS of the EuroQol was obtained by
dividing the number marked on the scale by 100, which was
transformed into a utility score ranging from 0 to 1.
From the SF-12, the utility of the six-dimensional health state
short form (derived from short-form 36 health survey) (SF-6D)
was calculated by applying the scoring method that was alsoderived from UK preference scores [15] because preference
weights of the SF-6D for Thai people were not available. The
scores of the KDQOL questionnaire were transformed into 0 to
100, with higher scores reflecting a better quality of life. Particular
health-related concerns of individuals with kidney disease and
on dialysis were symptom/problems, effects of kidney disease,
and burden of kidney disease [12].
Statistical Analysis
All analyses were conducted by using SPSS version 18. Reliability
was assessed by using intraclass correlation coefficients (ICCs) for
test-retest reliability evaluation and Cronbach’s alpha for internal
consistency. The test-retest reliability was conducted over face-to-
face interviews by repeating the measurement process on the
same subjects (30 hemodialysis patients) under the same con-
ditions. ICCs ranged from 0 to 1, with values close to 0 indicating
low reliability. For validity testing, discriminant validity of the
KDQOL-36 questionnaire (Thai) was analyzed by comparing the
mean of the two groups (lowest through 25 percentile and higher
than 75 percentile) with the Mann-Whitney U test. A P value of less
than 0.05 was considered statistically significant. Convergent
validity was analyzed by correlation between the SF-12 score,
the utility score (the SF-6D, the EQ-5D questionnaire, and the VAS),
and kidney disease–targeted scores.Results
Patient Characteristics
The mean  SD age of the HD respondent sample was
57.45  15.09 years; 47.90% of the respondents were men, and
more than half of the respondents had at least one underlying
disease such as hypertension (81.80%) and diabetes (23.00%). The
duration of hemodialysis was 7.44  5.42 years, and more than
half of the respondents had hemodialysis three times per week.
The mean  SD age of PD respondent sample was 67.60  11.45
years; 50.90% of the respondents were men, and more than half
of the respondents had at least one underlying disease such as
hypertension (63.20%) and diabetes (61.40%). The duration of
peritoneal dialysis was 1.92  1.20 years, 56.10% of the respond-
ents were on automated peritoneal dialysis, and 43.90% of the
respondents were on continuous ambulatory peritoneal dialysis.
Internal Consistency Reliability
The mean values for the kidney disease-specific scales for PD
patients ranged from 52.52 to 80.43, while the mean values for
the kidney disease-specific scales for HD patients ranged from
49.25 to 80.45 on the total possible (0-100) scores. Internal
consistency reliability of the three subscales in the kidney
disease–specific scale (the Symptom/Problem List, Effects of
Kidney Disease on Daily Life, and Burden of Kidney Disease)
was good for both HD and PD (Cronbach’s a of HD ¼ 0.799–0.827,
PD ¼ 0.706–0.781), as shown in Table 1.
Table 2 – Cronbach’s coefficient a, corrected item-total correlation, and a if item deleted of dialysis patient (PD
¼ 62, HD ¼ 167).




PD HD PD HD PD HD
Symptom/Problem List 12 0.763 0.799
14A 0.385 0.493 0.748 0.780
14B 0.293 0.326 0.757 0.795
14C 0.291 0.260 0.757 0.799
14D 0.393 0.437 0.747 0.785
14E 0.464 0.457 0.738 0.784
14F 0.597 0.623 0.725 0.768
14G 0.369 0.451 0.755 0.784
14H 0.500 0.362 0.734 0.791
14I 0.587 0.610 0.725 0.767
14J 0.328 0.403 0.754 0.789
14K 0.411 0.443 0.746 0.785
14L 0.166 0.475 0.766 0.781
Burden of Kidney Disease 4 0.781 0.802
12A 0.636 0.658 0.701 0.731
12B 0.682 0.654 0.676 0.734
12C 0.577 0.655 0.732 0.733
12D 0.459 0.503 0.792 0.806
Effects of Kidney Disease on Daily Life 8 0.706 0.827
15A 0.256 0.574 0.703 0.804
15B 0.412 0.612 0.674 0.799
15C 0.272 0.539 0.703 0.809
15D 0.569 0.610 0.631 0.798
15E 0.433 0.541 0.669 0.808
15F 0.520 0.566 0.648 0.804
15G 0.259 0.315 0.702 0.833
15H 0.430 0.638 0.670 0.794
HD, hemodialysis; PD, peritoneal dialysis.
Table 3 – Comparison between the first and the second time of score by Wilcoxon signed-ranks test, intraclass
correlation (ICCs) of each dimension (n ¼ 30).
Item Mean  SD P ICCs
I II
SF-12
SF-12 Physical Composite Score 44.77  8.50 45.11  8.05 0.873 0.966
SF-12 Mental Composite Score 52.03  10.04 51.51  9.66 0.838 0.957
Kidney disease–targeted scores
Symptom/Problem List 80.83  14.77 80.63  14.09 0.593 0.988
Effects of Kidney Disease on Daily Life 62.92  25.65 62.71  25.65 0.317 0.999
Burden of Kidney Disease 45.83  36.93 45.63  37.00 0.655 0.998
ICCs, intraclass correlation coefficients; SF-12, short-form 12 health survey.
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of the KDQOL-36 questionnaire when applying it to PD and HD
patients. By exploring the alpha if the 14L item (the KDQOL-36
questionnaire item on problems with the access site) was
deleted, the reliability of the scale (alpha) would increase more
than 0.763 in PD patients for the Symptoms/Problems List
domain. For the Burden of Kidney Disease domain, the reliability
of the scale (alpha) would increase from 0.781 to 0.792 (for PD)
and from 0.802 to 0.806 (for HD) if the 12D item (the KDQOL-36
questionnaire question on the patients feel like a burden on their
family) was deleted. For the Effects of Kidney Disease on Daily
Life domain, the removal of any question except question 15G(the KDQOL-36 questionnaire item on sex life) would result in a
lower Cronbach’s alpha (for HD). The corrected item-total corre-
lation value, however, was higher than 0.700; thus, we would not
consider removing any questions. The results suggest that this
Thai version of the KDQOL-36 questionnaire was well suited and
reliable for use in the Thai dialysis population.Test-Retest Reliability
The difference in mean ranks of the KDQOL-36 questionnaire
between the first and the second tests was not significant
(Wilcoxon signed-ranks test, P4 0.05). ICCs ranged from 0.966 to
Table 4 – Comparison between the low- and high-score group of 229 dialysis patients.
Scale 25 percentile 75 percentile P
Kidney disease–targeted scores
Symptom/Problem List 53.79  9.22 96.07  2.26 o0.001
Burden of Kidney Disease 6.01  6.89 91.91  9.36 o0.001
Effects of Kidney Disease on Daily Life 41.24  13.41 99.13  1.42 o0.001
Table 5 – Correlation of kidney disease–targeted scores, PCS, MCS, and utility scores (PD ¼ 62, HD ¼ 167).
Dimension Symptom/Problem
List




PD HD PD HD PD HD
SF-6D 0.556 0.579 0.292y 0.458 0.024 0.462
EQ-5D questionnaire (UK) 0.504 0.369 0.243y 0.204y 0.048 0.352
EQ-5D questionnaire (TH) 0.428 0.348 0.180 0.162y 0.021 0.311
VAS 0.477 0.384 0.333y 0.367 0.445 0.416
PCS 0.575 0.442 0.183 0.226y 0.172 0.327
MCS 0.531 0.542 0.390y 0.517 0.272y 0.472
EQ-5D, EuroQol five-dimensional; HD, hemodialysis; MCS, Mental Component Score; PCS, Physical Component Score; PD, peritoneal dialysis;
SF-6D, six-dimensional health state short form (derived from short-form 36 health survey); TH, Thailand; VAS, visual analogue scale.
* Po 0.001.
y Po 0.05.
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ICCs of more than 0.900: Symptoms/Problems List (ICC ¼ 0.988),
Effects of Kidney Disease (ICC ¼ 0.999), and Burden of Kidney
Disease on Daily Life (ICC ¼ 0.998); the SF12, both SF-12 PCS and
SF-12 MCS, had ICCs of more than 0.900, as shown in Table 3.
Construct Validity
Construct validity of 229 dialysis patients (HD ¼ 167, PD ¼ 62) was
satisfactory, with statistically significant difference between low-
and high-score groups, as shown in Table 4.
Spearman’s correlation of HD patients between kidney
disease–targeted scores, PCS, MCS, and utility scores had a
positive correlation, and all these correlations were statistically
significant (Po 0.05), while Spearman’s correlations between
most of the utility scores (the SF-6D and the EQ-5D question-
naire) and the Burden of Kidney Disease domain of PD patients
were not statistically significant (P4 0.05), as shown in Table 5.Discussion
Implications of dialysis patient care were not only the manage-
ment of dialysis-related complications but also the well-being of
patients [16]. Quality of life was important to consider patient
preferences for ESRD patient care [2]. The questionnaire was one
of the most commonly used instruments to assess and measure
quality of life [5]. The increasing number of patients with ESRD in
Thailand has created a demand for comparison, monitoring, and
evaluation of outcomes across different treatment methods. The
KDQOL-36 questionnaire was the preferred measurement tool for
large-scale assessments in dialysis facilities because of its ease of
administration with relatively minimal burden on patients; the
KDQOL-36 questionnaire took approximately 15 minutes to com-
plete. For 167 HD patients and 62 PD patients, results of internal
consistency were satisfactory, with Cronbach’s alpha higher than
0.7 for all domains. The corrected item-total correlation value was
higher than 0.7. The result suggested that this Thai version of theKDQOL-36 questionnaire was well suited and reliable for use in
the Thai dialysis population. When comparing the reliability of the
Thai version of the KDQOL-36 questionnaire with that of the Thai
version of the KDQOL-SFv.1.3, the Cronbach’s alpha in dialysis
patients for all domains in the Thai version of the KDQOL-36
questionnaire ranged between 0.706 and 0.827, which were higher
than for the Thai language KDQOL-SFv.1.3 (Cronbach’s alpha of
dialysis ¼ 0.44–0.86). About ICCs, this Thai version of the KDQOL-
36 questionnaire had ICCs ranging from 0.957 to 0.999 while the
Thai version of the KDQOL-SFv.1.3 from a previous study had ICCs
ranging from 0.531 to 0.952 [17]. This difference may be due to the
fewer items of the KDQOL-36 questionnaire. Construct validity of
229 dialysis patients (HD ¼ 167, PD ¼ 62) was satisfactory, with
statistically significant difference between low- and high-score
groups. Reliability and validity of this study, however, were
evaluated by face-to-face interview; thus, other collection
methods such as self-administration, telephone interviews, and
computer-assisted interviews may reflect different results.Conclusion
The present study reported the evidence for the reliability and
validity of the Thai version of the KDQOL-36 questionnaire. All
results suggested that the Thai version of the KDQOL-36 ques-
tionnaire was valid, reliable, and suitable for the dialysis patient
care in terms of measuring and understanding the HRQOL status.Acknowledgments
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